Abstract
IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition that rarely involves the central nervous system (CNS). When it does, it typically presents as hypertrophic pachymeningitis (thickening of the dura mater). We report a rare case of a 61-year-old man with progressive cognitive decline due to isolated leptomeningitis and parenchymal involvement. Despite normal serum IgG4 levels and no systemic involvement, a brain biopsy confirmed the diagnosis. Treatment with corticosteroids led to complete clinical and radiological recovery, highlighting the importance of considering IgG4-RD in atypical neurological presentations.
Introduction
IgG4-related disease (IgG4-RD) is characterized by lymphoplasmacytic infiltration rich in IgG4-positive plasma cells and storiform fibrosis. While it commonly affects the pancreas and salivary glands, CNS involvement is infrequent. Most CNS cases manifest as pachymeningitis. This case explores a more elusive presentation: isolated involvement of the pia mater (leptomeningitis) and the brain parenchyma, mimicking symptoms of dementia or a primary brain tumor.
Methods
The diagnosis was established through a multi-modal clinical approach:
- Cognitive Assessment: Standardized tools, including the Mini-Mental State Examination (MMSE) and Frontal Assessment Battery (FAB), quantified the patient's cognitive impairment.
- Neuroimaging: High-resolution 3.0T MRI utilized Fluid-Attenuated Inversion Recovery (FLAIR) and T1-weighted sequences with gadolinium contrast to map the lesions.
- Histopathology: A brain biopsy provided the definitive diagnosis. Tissue samples underwent Hematoxylin and Eosin (HE) staining and immunohistochemical (IHC) analysis for CD138, κ/λ light chains, IgG, and IgG4.
Results
Initial MRI revealed significant hyperintensities in the left frontal lobe on FLAIR imaging and distinct linear enhancement along the pia mater on post-contrast T1-weighted images.
The brain biopsy revealed dense inflammatory cell infiltration. Crucially, the inflammation extended from the meninges into the cerebral cortex, confirming the parenchymal involvement suspected from imaging.
Immunohistochemical staining showed a high ratio of IgG4-positive cells to total IgG cells (40%), meeting the threshold for "Probable IgG4-RD" according to the 2020 Revised Comprehensive Diagnostic Criteria. Following methylprednisolone pulse therapy and oral prednisone, the patient’s MMSE score improved from 23/30 to a perfect 30/30, and follow-up imaging showed near-complete resolution of the lesions.
Discussion
This case provides several key clinical insights:
- The "Normal Blood Work" Trap: Normal serum IgG4 levels do not rule out IgG4-RD. In this patient, relying on blood work alone would have led to a diagnostic failure.
- Atypical Pathology: Classic histological features of IgG4-RD, such as storiform fibrosis and obliterative phlebitis, were absent in this brain biopsy. This suggests that the pathological "signature" of the disease may vary when it occurs in the CNS compared to other organs.
- Classification Limitations: Current international criteria (e.g., 2019 ACR/EULAR) may exclude isolated CNS cases because they prioritize high specificity and common organ involvement (like the pancreas or salivary glands).
- Reversibility: The dramatic response to steroids emphasizes that IgG4-related leptomeningitis is a treatable, potentially curable cause of cognitive decline.
Conclusion
Clinicians should maintain a high index of suspicion for IgG4-RD when encountering unexplained leptomeningeal or parenchymal lesions, even in the absence of systemic symptoms or elevated serum IgG4. Early biopsy and histopathological confirmation are vital for initiating life-changing corticosteroid therapy.
Summary updated